Immunoprecipitation Market Growth Values, Demand Overview and Industry Forecast to 2023


Market Overview:
Market Research Future (MRFR) announces the publication of its research report –Immunoprecipitation Market, 2018 to 2023. It is estimated that the global immunoprecipitation market is expected to hold a market value of USD 562 million and register a CAGR 5.2 % during the forecast period of 2018 to 2023.
.
Immunoprecipitation is the method of precipitating a protein antigen from a solution by using an antibody that exactly binds to that particular protein. It is used for isolation and concentration of a particular protein from a sample that contains thousands of different proteins. The rising number of research activities in the life sciences sector and increasing need to identify antigens associated with autoimmune diseases are driving the market growth. According to a report published by the British Society of Immunology in March 2016, more than 80 autoimmune diseases have been identified. Additionally, increasing investments by governments and industries, rising biotechnology research across the globe, and growing awareness about personalized therapeutics is fueling the market growth.

Some of the key players in the global immunoprecipitation market are Abcam plc, GenScript, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Merck KGaA, BioLegend, Inc., Takara Bio Inc., Rockland Immunochemicals Inc., Cell Signaling Technology, Inc., and Geno Technology Inc.
However, the presence of alternative technologies for protein purification may negatively affect market growth during the forecast period.
On a regional basis, the immunoprecipitation market in the Americas is anticipated to dominate the market during the forecast period. The market growth in this region is owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the immunoprecipitation market in the region.
Currently, the global immunoprecipitation market is dominated by several players. The prominent players in this market are involved in product approvals, new product launches, and strategic partnerships to expand their product portfolio.  For instance, in July 2018, GenScript Biotech opened a contract development and manufacturing organization (CDMO) in Zhenjiang, China. This development helped the company to expand its presence in the Asia Pacific region.
The global immunoprecipitation market has been segmented into type, product, and end-user.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more